期刊文献+

HBV/HCV相关性肝细胞癌抗病毒治疗专家建议 被引量:8

原文传递
导出
摘要 乙型肝炎病毒(hepatitis B virus,HBV)和丙型肝炎病毒(hepatitis C virus,HCV)感染在肝细胞癌(hepatic celluler cancer,HCC)的发生发展中起重要作用。我国近年发布的《慢性乙型肝炎防治指南(2010版)》和《原发性肝癌诊疗规范(2011版)》都强调了肝癌患者抗病毒治疗的重要性,
出处 《中华实验和临床感染病杂志(电子版)》 CAS 2012年第6期124-128,共5页 Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)
基金 国家科技重大专项"艾滋病和病毒性肝炎等重大传染病防治"课题[No.2012ZX10002-016]
  • 相关文献

参考文献4

二级参考文献42

  • 1慢性乙型肝炎防治指南[J].中华传染病杂志,2005,23(6):421-431. 被引量:822
  • 2Lok AS,McMahon BJ,Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
  • 3Liaw YF,Leung N,Guan R,et al.Asian-Pacific consensus statement on the management of chronic hepatitis B:an update.J Gastroenterol Hepatol,2003,18:239-245.
  • 4Liaw YF,Sung JJ,Chow WC,et al.Lamivudine for patients with chronic hepatitis B and advanced liver disease.N Engl J Med,2004,351:1521-1531.
  • 5Liaw YF,Lin DY,Chen TJ,et al.Natural course after the development of cirrhosis in patients with chronic type B hepatitis:a prospective study.Liver,1989,9:235-241.
  • 6Beasley RP.Hepatitis B virus.The major etiology of hepatocellular carcinoma.Cancer,1988,61:1942-1956.
  • 7Everhart JE,Hoofnagle JH.Hepatitis B-related end-stage liver disease.Gastroenterology,1992,103:1692-1694.
  • 8Lai CL,Chien RN,Leung NW,et al.A one-year trial of lamivudine for chronic hepatitis B.Asia Hepatitis Lamivudine Study Group.N Engl J Med,1998,339:61-68.
  • 9Dienstag JL,Schiff ER,Wright TL,et al.Lamivudine as initial treatment for chronic hepatitis B in the United States.N Engl J Med,1999,341:1256-1263.
  • 10Goodman Z,Dhillon AP,Wu PC,et al.Lamivudine treatment reduces progression to cirrhosis in patients with chronic hepatitis B.J Hepatol,1999,30 Suppl 1:S59.

共引文献150

同被引文献62

引证文献8

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部